Reducing biological risk and enhancing global biosecurity

Biological threats have the potential to kill millions, cost billions in economic losses, and create political and economic instability, whether naturally occurring, accidental, or manmade. The risk of a catastrophic biological event is magnified by global travel, urbanization, terrorist interest in weapons of mass destruction as well as rapid advances in technology, including risks posed by newly developed or manipulated pathogens with pandemic potential. 

All of these factors taken together create an urgent need to strengthen biosecurity, reduce biological risks posed by advances in technology, create new approaches to improve infectious disease surveillance, and identify and fill gaps to measurably strengthen global health security capabilities.  Despite these challenges, biosecurity remains an under-emphasized and under-financed global security priority.

NTI recognizes that threat reduction is a shared responsibility between governments and the private sector. We raise awareness, advocate for solutions, facilitate implementation of solutions, and foster new thinking about these challenges. Specifically, NTI seeks to reduce biological risks by:

  • Defining concrete actions to reduce risks posed by advances in technology and engaging global stakeholders to implement them.
  • Identifying gaps in the capacity of individual countries to mitigate high-consequence biological events and motivate governments and other stakeholders to fill them.
  • Developing new approaches for curbing the catastrophic outcomes from a high-consequence biological event, including catalyzing progress toward real-time biosurveillance and pandemic forecasting.
  • Increasing international biosecurity capabilities and raising the profile of biosecurity within the Global Health Security Agenda (GHSA), which is a group of over 60 countries and international organizations dedicated to preventing, detecting, and responding to infectious disease threats.
Protect Health Security

Related Projects

bio group

Global Health Security Index

The GHS Index will highlight individual country needs, boost compliance with international standards, and create better understanding of global capabilities to prevent, detect, and respond to biological threats.

Global Biosecurity Dialogue

NTI’s Global Biosecurity Dialogue brings together senior officials from ministries of foreign affairs, health, defense, agriculture and other relevant sectors to address limitations in biosecurity and identify new and measurable actions to advance international biosecurity.
 Fostering Biosecurity Innovation and Risk Reduction

Biosecurity Innovation and Risk Reduction Initiative

NTI | bio is working with stakeholders around the world to mitigate the misuse of tools and technologies to carry out biological attacks and to reduce the risk of a laboratory accident that could result in a high-consequence or catastrophic biological event.

Connecting Organizations for Regional Disease Surveillance

A non-governmental initiative to facilitate global cooperation and capacity among public health experts and communities, to enhance health security

Middle East Consortium on Infectious Disease Surveillance

The Middle East Consortium on Infectious Disease Surveillance, centered in one of the world’s most turbulent regions, builds unprecedented cooperation among public health authorities in preparing for and responding to biosecurity and disease threats.

Mekong Basin Disease Surveillance Network

The Mekong Basin Disease Surveillance Network strengthens national and sub-regional capabilities in infectious disease surveillance and outbreak response in Cambodia, Thailand, China, Vietnam, Myanmar, and Laos.

NTI-WHO Global Emergency Outbreak Response Fund

NTI helped the World Health Organization establish and build a fund to allow teams of epidemiologists to deploy immediately to investigate and respond to disease outbreaks around the globe.
Bio Suit Under Hood

Tuberculosis Threat in North Korea

To address the surging number of tuberculosis cases in North Korea, the Stanford University-led Bay Area TB Consortium worked with NTI and other groups to establish a local lab capable of detecting drug-resistant strains of tuberculosis.